Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01Fand T121E02F in Healthy Postmenopausal Women

NCT01721993 is registered in ClinicalTrials.gov with Thar Pharmaceuticals, Inc as lead sponsor.

NCT NCT01721993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01721993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01Fand T121E02F in Healthy Postmenopausal Women
Lead sponsor
Thar Pharmaceuticals, Inc
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2013
Completion date
August 31, 2014
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy postmenopausal women